STAT3-IN-1
CAS No. 2059952-75-7
STAT3-IN-1( —— )
Catalog No. M21979 CAS No. 2059952-75-7
STAT3-IN-1 selective and orally active inhibitor of STAT3(in HT29 and MDA-MB 231 cells, with IC50 values of 1.82 μM and 2.14 μM , respectively), induces tumor apoptosis.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 132 | In Stock |
|
| 2MG | 77 | In Stock |
|
| 5MG | 126 | In Stock |
|
| 10MG | 193 | In Stock |
|
| 25MG | 350 | In Stock |
|
| 50MG | 512 | In Stock |
|
| 100MG | 737 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 1516 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSTAT3-IN-1
-
NoteResearch use only, not for human use.
-
Brief DescriptionSTAT3-IN-1 selective and orally active inhibitor of STAT3(in HT29 and MDA-MB 231 cells, with IC50 values of 1.82 μM and 2.14 μM , respectively), induces tumor apoptosis.
-
DescriptionSTAT3-IN-1 selective and orally active inhibitor of STAT3(in HT29 and MDA-MB 231 cells, with IC50 values of 1.82 μM and 2.14 μM , respectively), induces tumor apoptosis. STAT3-IN-1 induces tumor cells apoptosis in MDA-MB-231 cells.
-
In VitroApoptosis Analysis Cell Line:MDA-MB-231 cell lines.Concentration:0-10 μM.Incubation Time:48 hours.Result:The induced apoptosis rates (early and late apoptosis) at 1, 2, 5, 8 and 10 μM were 9.0%, 11.2%, 20.9%, 43.3% and 85.2% versus control 3.0%.Western Blot Analysis Cell Line:MDA-MB-231 and HT-29 cell lines.Concentration:0-10 μM.Incubation Time:48 hours.Result:Inhibited STAT3 acetylation and STAT3 tyrosine phosphorylation in MDA-MB-231 cells.Increased the expressions of these tumor-suppressor genes (PTPN6 (SHP-1), CDKN2A and DLEC1) which were related to STAT3 acetylation at Lys685.
-
In VivoAnimal Model:Mouse-xenograft model bearing inoculation of mice breast cancer 4T1 cells.Dosage:10, 20 mg/kg. Administration:Oral administration once every other day for two weeks.Result: Arrested tumor growth with no obvious body weight loss.
-
Synonyms——
-
PathwayJAK/STAT Signaling
-
TargetSTAT
-
RecptorSTAT3
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2059952-75-7
-
Formula Weight475.53
-
Molecular FormulaC28H29NO6
-
Purity>98% (HPLC)
-
SolubilityDMSO:125 mg/mL?(262.86 mM;?Need ultrasonic)
-
SMILESCOc1cc(OC)cc(\C=C\c2ccc(NC(=O)\C=C\c3cc(OC)c(OC)c(OC)c3)cc2)c1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Li S, et al. Discovery of oral-available resveratrol-caffeic acid based hybrids inhibiting acetylated and phosphorylated STAT3 protein. Eur J Med Chem. 2016 Nov 29;124:1006-1018.
molnova catalog
related products
-
NT219
NT219 is a dual inhibitor of insulin receptor substrate 1/2 (IRS1/2) and STAT3, enhances the aggregation of misfolded prion protein NT219 affects the levels of certain molecular chaperones and inhibits STAT3 phosphorylation NT219 is useful for the study of cancer and neurodegenerative diseases.
-
STAT3-IN-13
STAT3-IN-13 is a potent STAT3 inhibitor.STAT3-IN-13 has antiproliferative and anticancer activity and acts by binding to the structural domain of STAT3 SH2.
-
Suptavumab
Suptavumab (REGN2222) is a human monoclonal antibody that neutralizes conserved epitopes on subtypes A and B of RSV, making it useful for studying RSV infections and the respiratory system.
Cart
sales@molnova.com